NCT06060691 is a Phase 1 clinical trial of Kaempferol in Female Sexual Dysfunction, sponsored by Deraya University.

Who is sponsoring NCT06060691?

NCT06060691 is sponsored by Deraya University.

What drugs are being tested in NCT06060691?

Interventions in NCT06060691: Kaempferol.

What condition does NCT06060691 study?

NCT06060691 studies Female Sexual Dysfunction.

Is NCT06060691 still recruiting?

NCT06060691 is currently completed. Last updated 16 May 2024.

Last reviewed 2024-05-16 · How we verify

NCT06060691

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

Completed Phase 1 Last updated 16 May 2024

What this trial tests

Phase 1 trial testing Kaempferol in Female Sexual Dysfunction in 30 participants. Completed in 1 February 2024.

Timeline

20 September 2023

Primary endpoint
30 December 2023

1 February 2024

Quick facts

Lead sponsor	Deraya University
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	20 September 2023
Primary completion	30 December 2023
Estimated completion	1 February 2024
Sites	1 location across Egypt

Drugs / interventions tested

Kaempferol — full drug profile →

Conditions studied

Female Sexual Dysfunction — all drugs for Female Sexual Dysfunction →

Sponsor

Deraya University

Who can join

Adults 28 to 45, female only, with Female Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol as an API

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Targeting mitochondrial quality control: new therapeutic strategies for major diseases.
Hong WL, Huang H, Zeng X, Duan CY. · · 2024 · cited 38× · PMID 39164792 · DOI 10.1186/s40779-024-00556-1
Research advances of <i>Zanthoxylum bungeanum Maxim.</i> polyphenols in inflammatory diseases.
Qi J, Pan Z, Wang X, Zhang N, et al · · 2024 · cited 14× · PMID 38343532 · DOI 10.3389/fimmu.2024.1305886
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs.
Nicoara C, Fezza F, Maccarrone M. · · 2025 · cited 4× · PMID 40214504 · DOI 10.3390/cells14070551

Verify or expand the search:

Other trials of Kaempferol

Trials testing the same drug.

NCT07322406 — Kaempferol Absorption and Pharmacokinetics Evaluation · NA · recruiting

Other recruiting trials for Female Sexual Dysfunction

Currently open trials in the same condition.

NCT06729151 — Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patient · recruiting
NCT06116045 — Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder · Phase 2 · recruiting
NCT06794346 — Sexual Effects of Transdermal or Vaginal Testosterone · Phase 2 · active not recruiting

Other Deraya University trials

Trials by the same sponsor.

NCT07528625 — Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People · NA · not yet recruiting
NCT07535827 — Insulin Intratympanic Application · EARLY_PHASE1 · enrolling by invitation
NCT07534280 — Herbal Tea Extract for Management of Rhinosinusitis · NA · completed
NCT07524686 — Spinal Mobilization With Leg Movement Versus Neurodynamic Mobilization in Lumbar Radiculopathy · NA · completed
NCT07368517 — Dry Needling for Mechanical Neck Pain · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06060691 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Deraya University
Last refreshed: 16 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06060691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing